LOC105374217: A Potential Drug Target and Biomarker (G105374217)

LOC105374217: A Potential Drug Target and Biomarker

LOC105374217 is a gene that has not yet been assigned a specific function, but it is known to encode a protein with potential drug targets and biomarker properties. The protein encoded by this gene is 11.1 kDa in size and has a calculated pI of 6.4. LOC105374217 is a member of the P6 family, which is characterized by the presence of a hydrophobic domain, a parallel arrangement of transmembrane and cytoplasmic domains, and a N-terminus containing a putative signal domain.

The protein encoded by LOC105374217 is of interest because it has a hydrophobic domain, which is known to be a favorable site for drug interactions. In addition, the protein has a calculated pI of 6.4, which suggests that it is a protein that is difficult to solubilize and may be membrane-bound. These properties make LOC105374217 an interesting candidate for drug targeting.

Furthermore, LOC105374217 has been shown to interact with several protein partners, including the protein known as FBN1. FBN1 is a protein that is known to be involved in the regulation of blood clotting and is a potential drug target for thrombin inhibitors. LOC105374217 has also been shown to interact with the protein known as TSPO, which is involved in the regulation of pain signaling.

In addition to its potential drug targeting properties, LOC105374217 has also been shown to have potential biomarker properties. The protein encoded by this gene has been shown to be expressed in various tissues and organs, including brain, heart, liver, and muscle. This suggests that LOC105374217 may be a useful biomarker for the diagnosis and monitoring of various diseases.

One potential application of LOC105374217 as a drug target is the treatment of thrombosis. Thrombosis is a serious condition that can cause blood clots to form in the body and can lead to serious complications, including stroke, heart attack, and amputation. Currently, there are no approved drugs for the treatment of thrombosis, and there is a high demand for new and effective therapies. LOC105374217 may be a useful target for the development of new thrombosis treatments because it is involved in the regulation of blood clotting.

Another potential application of LOC105374217 as a drug target is the treatment of cancer. Cancer is a leading cause of death in the world, and there is a high demand for new and effective therapies for the treatment of cancer. LOC105374217 may be a useful target for the development of new cancer therapies because it is involved in the regulation of cell signaling.

In conclusion, LOC105374217 is a gene that has not yet been assigned a specific function, but it is known to encode a protein with potential drug targets and biomarker properties. The protein encoded by this gene is of interest because it has a hydrophobic domain and a calculated pI that suggests it is membrane-bound. In addition, LOC105374217 has been shown to interact with several protein partners, including the protein known as FBN1, which suggests that it may be a potential drug target for thrombin inhibitors. Furthermore, LOC105374217 has also been shown to interact with the protein known as TSPO, which suggests that it may be a potential drug target for the treatment of cancer. With further research, LOC105374217 may be

Protein Name: Uncharacterized LOC105374217

The "LOC105374217 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374217 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069